SRSF2 and myelodysplastic syndrome: The most commonly mutated group of genes at the time of MDS diagnosis are the spliceosome genes: SF3B1 (~25%–30%), SRSF2 (~15%), U2AF1 (~7%–11%), and ZRSR2 (~5%) (Figure 2).